Weiguo Ye insider trades

Open-market stock purchases and sales by Weiguo Ye, Chief Operating Officer at Gyre Therapeutics, Inc, from SEC Form 4 filings since Nov 20, 2023.

Recent trades

DateStockTradeValue
Jun 18, 2026GYRE Gyre Therapeutics, IncSold$19.1K
Jun 18, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
Jun 11, 2026GYRE Gyre Therapeutics, IncSold$17.3K
Jun 11, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
Jun 10, 2026GYRE Gyre Therapeutics, IncSold$39.9K
Jun 10, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
Jun 10, 2026GYRE Gyre Therapeutics, IncSold$31.2K
Jun 10, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
Jun 9, 2026GYRE Gyre Therapeutics, IncSold$89K
Jun 9, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
Jun 9, 2026GYRE Gyre Therapeutics, IncSold$18.4K
Jun 9, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
Jun 5, 2026GYRE Gyre Therapeutics, IncSold$98.6K
Jun 5, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
Jun 4, 2026GYRE Gyre Therapeutics, IncSold$120K
Jun 4, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
May 26, 2026GYRE Gyre Therapeutics, IncSold$24.4K
May 26, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
May 22, 2026GYRE Gyre Therapeutics, IncSold$21.3K
May 22, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
May 21, 2026GYRE Gyre Therapeutics, IncSold$78.8K
May 21, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
May 20, 2026GYRE Gyre Therapeutics, IncSold$57.8K
May 20, 2026GYRE Gyre Therapeutics, IncBought (not open market)—
May 19, 2026GYRE Gyre Therapeutics, IncSold$58.1K

Companies traded

  • GYRE Gyre Therapeutics, Inc: 16 sales, last Jun 18, 2026

Get free alerts when Weiguo Ye files a new trade →